CAD patients showed increased plasma levels of inflammatory markers, including IL-6, TNFα and hs-CRP C. Our results are in agreement with previous findings [23], in demonstrating that plasma levels of several mediators of inflammation (eg, IL-6, TNFα and hs-CRP) are increased in CAD patients compared to controls. Here, IL6 is linked to coronary artery disorder.